دورية أكاديمية

A phase 1 study of TPST-1495 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors.

التفاصيل البيبلوغرافية
العنوان: A phase 1 study of TPST-1495 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors.
المؤلفون: Ulahannan, Susanna Varkey, Powderly, John D., Johnson, Melissa Lynne, Krauss, John C., Sharma, Manish, Davar, Diwakar, Karasic, Thomas Benjamin, Gaillard, Stephanie, Jenkins, Yonchu, Stagg, Robert J., Bomba, Darrin, Standifer, Nathan, Smith, Steven, Prasit, Peppi, Dubensky, Thomas Walter, Whiting, Sam H., Papadopoulos, Kyriakos P.
المصدر: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3107-3107, 1p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2023.41.16_suppl.3107